Connection
Raj Wadwa to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Raj Wadwa has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.540 |
|
|
|
-
Bjornstad P, Wadwa RP. Risks and benefits of statin use in young people with type 1 diabetes. Curr Diab Rep. 2014 Jul; 14(7):499.
Score: 0.353
-
Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, Eckel RH, Rewers M. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care. 2005 May; 28(5):1051-6.
Score: 0.187